A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions

Clinical trial NCT04363242 · UNKNOWN

Trial details

NCT number: NCT04363242
Sponsor: Synermore Biologics Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Carcinoma Solid Tumor

Start date: 2020-04-09
Primary completion: 2023-07-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.